Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I-III pancreatic ductal adenocarcinoma: a retrospective cohort study.
Yiping ZouSong GaoXin YuTianxing ZhouYongjie XieXiaofan GuoRan AnXiuchao WangTiansuo ZhaoAntao ChangChuntao GaoJun YuJihui HaoPublished in: International journal of surgery (London, England) (2023)
Neoadjuvant therapy followed by surgery could improve OS over upfront surgery in Stage IB-III PDAC but did not provide a significant survival advantage in Stage IA PDAC.